Polypharmacy among Older Individuals with COPD: Trends between 2000 and 2015 in Quebec, Canada

References

• Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28:523–532. doi: 10.1183/09031936.06.00124605.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir Res. 2017;18:67. doi: 10.1186/s12931-017-0548-3.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD); Global Strategy for the Diagnosis, Management and Prevention of COPD. [Internet]. [cited 2019 Jan 25]. Available from: https://goldcopd.org.
   Google Scholar
• Hanlon P, Nicholl BI, Jani BD, et al. Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study. BMJ Open. 2018;8:e018404. doi: 10.1136/bmjopen-2017-018404.
   PubMed Web of Science ®Google Scholar
• Chetty U, McLean G, Morrison D, et al. Chronic obstructive pulmonary disease and comorbidities: a large cross-sectional study in primary care. Br J Gen Pract. 2017;67:e321–e328. doi: 10.3399/bjgp17X690605.
   PubMed Web of Science ®Google Scholar
• Nagewo NA, Gibson PG, Wark PA. Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:2929–2942. doi: 10.2147/COPD.S136256.
   PubMed Web of Science ®Google Scholar
• Blais C, Jean S, Sirois C, et al. Quebec Integrated Chronic Disease Surveillance System (QICDSS), an innovative approach. Chronic Dis Inj Can. 2014;34:226–235.
   PubMedGoogle Scholar
• Simard M, Sirois C, Candas B. Validation of the combined comorbidity index of Charlson and Elixhauser to predict 30-day mortality across ICD-9 and ICD-10. Med Care. 2018;56:441–447. doi: 10.1097/MLR.0000000000000905.
   PubMed Web of Science ®Google Scholar
• Gershon AS, Wang C, Guan J, et al. Identifying individuals with physician-diagnosed COPD in health administrative databases. Can Respir J. 2009;6:388–394. doi: 10.1080/15412550903140865.
   Web of Science ®Google Scholar
• Doucet M, Rochette L, Hamel D. Incidence, prevalence, and mortality trends in chronic obstructive pulmonary disease over 2001 to 2011: A public health point of view of the burden. Can Respir J. 2016;2016:1. doi: 10.1155/2016/7518287.
   Web of Science ®Google Scholar
• Feely A, Lix LM, Reimer K. Estimating multimorbidity prevalence with the Canadian Chronic Disease Surveillance System. Health Prom Chronic Dis Prev Can. 2017;37:215–222. doi: 10.24095/hpcdp.37.7.02.
   PubMed Web of Science ®Google Scholar
• Canadian Institute for Health Information. Drug use among seniors in Canada, 2016. [Internet].Ottawa, ON: CIHI; 2018. [cited 2019 Jan 28]. Available from: https://www.cihi.ca/sites/default/files/document/drug-use-among-seniors-2016-en-web.pdf.
   Google Scholar
• Vertrano DL, Bianchini E, Onder G, et al. Poor adherence to chronic obstructive pulmonary disease medications in primary care: role of age, disease burden and polypharmacy. Geriatr Gerontol Int. 2017;17:2500–2506. doi: 10.1111/ggi.13115.
   PubMed Web of Science ®Google Scholar
• Guthrie B, Makubate B, Hernandez-Santiago V, et al. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010. BMC Med. 2015;13:74. doi: 10.1186/s12916-015-0322-7.
   PubMed Web of Science ®Google Scholar
• Reeve E, Wiese M, Mangoni A. Alterations in drug disposition in older adults. Expert Opin Drug Metab Toxicol. 2015;11:491–508. doi: 10.1517/17425255.2015.1004310.
   PubMed Web of Science ®Google Scholar
• Sirois C, Simard M, Gagnon ME, et al. Mixed bag polypharmacy: methodological pitfalls and challenges of this exposure definition. Curr Epidemiol Rep. 2019. https://doi.org/10.1007/s40471-019-00214-4
   Google Scholar
• Sganga F, Landi F, Ruggiero C, et al. Polypharmacy and health outcomes among older adults discharged from hospital: results from the CRIME study. Geriatr Gerontol Int. 2015;15:141–146. doi: 10.1111/ggi.12241.
   PubMed Web of Science ®Google Scholar
• Payne RA, Abel GA, Avery AJ, et al. Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care. Br J Clin Pharmacol. 2014;77:1073–1082. doi: 10.1111/bcp.12292.
   PubMed Web of Science ®Google Scholar
• Fried TR, O'Leary J, Towle V, et al. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62:2261–2272. doi: 10.1111/jgs.13153.
   PubMed Web of Science ®Google Scholar
• Gutierrez-Valencia M, Izquierdo M, Cesari M, et al. The relationship between frailty and polypharmacy in older people: a systematic review. Br J Clin Pharmacol. 2018;84:1432–1444. doi: 10.1111/bcp.13590.
   PubMed Web of Science ®Google Scholar
• Graf J, Lucke T, Herrera R, et al. Compatibility of medication with PRISCUS criteria and identification of drug interactions in a large cohort of patients with COPD. Pulm Pharmacol Ther. 2018;49:123–129. doi: 10.1016/j.pupt.2018.01.011.
   PubMed Web of Science ®Google Scholar
• Price D, West D, Brusselle G, et al. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns. Int J Chron Obstruct Pulmon Dis. 2014;9:889–904. doi: 10.2147/COPD.S62750.
   PubMed Web of Science ®Google Scholar
• Sirois C, Lunghi C, Laroche M-L, et al. The delicate choice of optimal basic therapy for multimorbid older adults: a cross-sectional survey. Res Social Adm Pharm. 2019;15:761–766. doi: 10.1016/j.sapharm.2018.09.008.
   PubMed Web of Science ®Google Scholar
• Houben-Wilke S, Triest FJJ, Franssen FME, et al. Revealing methodological challenges in chronic obstructive pulmonary disease studies assessing comorbidities: a narrative review. Chronic Obstr Pulm Dis. 2019;6:166–177. doi: 10.15326/jcopdf.6.2.2018.0145.
   PubMed Web of Science ®Google Scholar
• Eroglu SA, Gunen H, Yakar HI, et al. Influence of comorbidities in long-term survival of chronic obstructive pulmonary disease patients. J Thorac Dis. 2019;11:1379–1386. doi: 10.21037/jtd.2019.03.78.
   PubMed Web of Science ®Google Scholar
• Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:155–161. doi: 10.1164/rccm.201201-0034OC.
   PubMed Web of Science ®Google Scholar
• Corsonello A, Scarlata S, Pedone C, et al. Treating COPD in older and oldest old patients. Curr Pharm Des. 2015;21:1672–1689.
   PubMed Web of Science ®Google Scholar
• Reilev M, Pottegård A, Davidsen JR, et al. Seventeen-year nationwide trends in use of long-acting bronchodilators and inhaled corticosteroids among adults: a Danish Drug Utilization Study. Basic Clin Pharmacol Toxicol. 2018;123:58–64. doi: 10.1111/bcpt.12978.
   PubMed Web of Science ®Google Scholar
• Crim C, Calverley PMA, Anderson JA, et al. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J. 2009;34:641–647. doi: 10.1183/09031936.00193908.
   PubMed Web of Science ®Google Scholar
• Suissa S, Patenaude V, Lapi F, et al. Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax. 2013;68:1029–1036. PMID:24130228. doi: 10.1136/thoraxjnl-2012-202872.
   PubMed Web of Science ®Google Scholar
• Bourbeau J, Bhutani M, Hernandez P, et al. CTS position statement: pharmacotherapy in patients with COPD – an update. Can J Respir Crit Care Sleep Med. 2017;1:222–241. doi: 10.1080/24745332.2017.1395588.
   Web of Science ®Google Scholar
• Kwark MJ, Kim J, Bhise V, et al. National trends in smoking cessation medication prescriptions for smokers with chronic obstructive pulmonary disease in the United States, 2007-2012. J Prev Med Public Health. 2018;51:257–262. doi: 10.3961/jpmph.18.119.
   PubMedGoogle Scholar
• Price D, Brusselle G. Challenges of COPD diagnosis. Expert Opin Med Diagn. 2013;7:543–556. doi: 10.1517/17530059.2013.842552.
   PubMedGoogle Scholar
• Güder G, Störk S. COPD and heart failure: differential diagnosis and comorbidity. Herz. 2019. doi: 10.1007/s00059-019-4814-7.
   PubMed Web of Science ®Google Scholar